Institution Subject number. Demographics Age (yrs) Male (0/1) Race (0/1) Hispanic Non-hispanic AA Asian
|
|
|
- Hubert Simon
- 5 years ago
- Views:
Transcription
1 Institution Subject number Demographics Age (yrs) Male (0/1) Race (0/1) Hispanic Non-hispanic AA Asian Co-morbidities (0/1) Hypertension Coronary artery disease If 1: Coronary stents History of cardiac surgery Non-insulin dependent diabetes Chronic alcohol abuse Congestive heart failure CVA/stroke Chronic drug abuse Insulin dependent diabetes Transplant history Psychiatric disorder Myocardial infarction Renal insufficiency (not on dialysis) Renal failure (on dialysis) Asthma Rheumatoid arthritis Parkinson s disease Cirrhosis Seizures COPD/Emphysema Mechanism (0/1) Blunt Fall Found down Motor vehicle crash
2 Motorcycle crash Recreational vehicle crash Auto vs. Pedestrian Assault Other Penetrating Stab wound GSW Other Injuries ISS AIS Head Face Neck Thorax Abdomen Spine Upper extremity Lower extremity Head injury Epidural hemorrhage Subdural hemorrhage Subarachnoid hemorrhage Intraparenchymal hemorrhage Spinal injury Fracture cervical Associated cord injury Fracture thoracic Associated cord injury Fracture lumbar Associated cord injury Fracture other without cord injury (ICD-10) code Fracture other with cord injury (ICD-10) code Injuries Other (ICD-10) Physiology on admit SBP on admit (mm Hg) SBP <90 (0/1) GCS (score)
3 GCS <9 (0/1) Base deficit (mmol/l) Hgb (g/dl) Alcohol screen done (0/1) Blood alcohol level (mg/dl) Urine toxicology done (0/1) Utox Negative Utox +cannabis Utox +cocaine Utox +PCP Utox +benzodiazapines Utox +barbiturates Utox +narcotics/opiates Utox +amphetamines Utox +methamphetamines Utox +other Transfer Was pt transferred to your TC? Outcomes Mechanical ventilation (0/1) Days ventilated (days) ICU admission (0/1) ICU-LOS (days) H-LOS (days) Disposition (0/1) Against Medical Advice Jail Psychiatric facility Home Rehab facility Skilled nursing facility Extended care facility Other acute care Facility/transfer Hospice Death <24 hrs >24 hrs Hosp day of death (day) Complications (0/1) Progression of brain injury Progression of neurological deficit Unplanned return to OR
4 PE DVT GIB Myocardial infarction CHF CVA/TIA AKI ALI ARDS Pneumonia UTI Bacteremia Cellulitis SSI CSF infection Heparin Induced Thrombocytopenia (HIT) Antiplatelet/coagulation Medications ASA (0/1) (<82mg vs >82mg) Clopidogrel (0/1) Prasugrel (0/1) Ticagrelor (0/1) Cangrelor (0/1) Dipyridamole (0/1) Dabigatran (0/1) Rivaroxaban (0/1) Apixaban (0/1) Edoxaban (0/1) Betrixaban (0/1) Other (agent) Labs on admit aptt (sec) PT (sec) INR TEG (if available) Platelet testing (mapping, VerifyNow, aggregometry) Platelet count BUN Creatinine Timing to normalization of coagulation parameters
5 PT/INR normal on admit aptt normal on admit Platelets normal on admit TEG normal on admit Time to normal PT/INR (hrs) Time to normal aptt (hrs) Time to normal platelets (hrs) Time to normal TEG (hrs) Interventions ICP monitor Bolt/Camino Date placed (Hosp day) Ventriculostomy Date placed (hosp day) Angiography (0/1) Diagnostic Embolization Stent Craniotomy Craniectomy Thoracotomy Sternotomy Laparotomy Surgery Other Timing to intervention (hrs) Time to ICP placement Time to craniotomy Time to craniectomy Time to thoracotomy Time to sternotomy Time to laparotomy Time to surgery other Hold anticoagulant (0/1) Reverse anticoagulant (0/1) Drug specific agent (0/1) Drug used Hemodialysis for reversal Hospital date agent resumed (day) Transfusion PRBC (units first 24hrs)
6 PRBC (units total) FFP (units first 24hrs) FFP (units total) Platelets (units first 24hrs) Platelets (units total) Cryoprecipitate (first 24hrs) Cryoprecipitate (units total) Factor VIIa (dose first 24hrs) Factor VIIa (dose total) Prothrombin complex (units first 24hrs) Prothrombin complex (units total) Protamine (dose first 24hrs) Protamine (dose total) Tranexamic acid (dose first 24hrs) Tranexamic acid (dose total) DDAVP (dose first 24hrs) DDAVP (dose total) Vitamin K (mg first 24hrs) Vitamin K (mg total) Complications Bleeding requiring intervention (0/1) Re-bleeding (0/1) Transfusion reaction Fever Rash TRALI TACO Anaphylaxis Hemolysis VTE prophylaxis Mechanical (0/1) Date mechanical (Hospital day) Pharmacologic (0/1) Heparin subcutaneous Enoxaparin Dalteparin Heparin infusion Other anticoagulant
7 Date pharmacological (Hospital day) Definitions Progression of brain injury: increase in size or severity of intracranial hemorrhage on imaging, or new intracranial hemorrhage on repeat imaging Progression of original neurological insult: deterioration or additional loss of function from that noted upon arrival in ED or trauma bay Unplanned return to OR: unexpected and/or unplanned return to the OR for same or similar procedure PE: embolus to the lungs documented by arteriography, nuclear scan or autopsy DVT: venous thrombosis involving the deep venous system confirmed by autopsy, venogram, duplex scan or non-invasive vascular evaluation GIB: secondary hemorrhage from the GI tract causing decrease in hematocrit >5% or requiring blood transfusion MI: acute irreversible myocardial injury and necrosis documented by increased troponin and serial T wave, ST segment or Q wave ECG changes or a diagnostic radionuclide scan CHF: syndrome of shortness of breath, fluid retention and fatigue associated with elevated cardiac filling pressures and inadequate peripheral oxygen delivery caused by cardiac dysfunction CVA/TIA: AKI: Increased SCr> 0.3mg/dL within 48 hours or SCr>1.5 times baseline ALI/ARDS = acute onset of hypoxemia with: Bilateral pulmonary infiltrates on chest x-ray Pulmonary capillary wedge pressure <18mmHg(2.4kPa) ALI=PaO2/FiO2 <300mmHg (40kPA) ARDS=PaO2/FiO2<200mmHg (40kPA) Pneumonia: presence of fever, leukocytosis, gram stain of sputum with predominant organism and white blood cells, chest x-ray with infiltrate and culture demonstrating a pathogen UTI: 50,000 colonies in a clean urine culture and/or presumptive diagnosis that leads to treatment with antibiotics Bacteremia: any positive blood culture excluding isolates that are felt to be contaminants
8 Cellulitis: skin/soft tissue infection as evidenced by drainage of purulent material from a wound or active treatment of the wound including opening a closed wound, or administering antibiotics for the wound (excluding prophylactic antibiotics) SSI: surgical site infection involving drainage of purulent material from wound requiring opening of a closed wound, or antibiotic therapy (excluding prophylactic antibiotics) CSF infection: positive culture of cerebrospinal fluid, positive culture of CSF, or >50% polymorphonuclear cells on cell count or minimum 50 cells counted or CSF sugar <15% or evidence of meningitis or encephalitis on MRI Heparin Induced Thrombocytopenia: positive immunoassay identifying antibodies against heparin/pf4 or positive serotonin releasing assay (SRA) or heparin-induced platelet aggregation assay (HIPA) Transfusion reactions 1. Fever = temperature 101.5F or 38.5C temporally related to blood transfusion 2. Rash = maculopapular skin lesions or hives temporally related to blood transfusion 3. TRALI = Meets criteria previously stated for ALI/ARDS with hypotension and fever that occurs within 6 hours of blood transfusion and has no other reasonable explanation of pulmonary symptoms. Usually resolves quickly 4. TACO = dyspnea, orthopnea, peripheral edema, rapid increase in blood pressure temporally related to blood transfusion
Data Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:
Data Collection Tool Standard Study Questions: Admission Date: Admission Time: Age: Gender: Specifics of Injury: Time of Injury: Mechanism of Injury Blunt vs Penetrating? Injury Severity Score? Injuries:
EAST MULTICENTER STUDY DATA DICTIONARY
EAST MULTICENTER STUDY DATA DICTIONARY Does the Addition of Daily Aspirin to Standard Deep Venous Thrombosis Prophylaxis Reduce the Rate of Venous Thromboembolic Events? Data Entry Points and appropriate
4. Which survey program does your facility use to get your program designated by the state?
TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and
ACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...
ACUTE KIDNEY INJURY (AKI)...122 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)...124 ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...10 AIRBAG DEPLOYMENT...30 AIS PREDOT CODE...118 AIS SEVERITY...119
High Risk + Challenging Trauma Cases. Hawaii. Topics 1/27/2014. David Thompson, MD, MPH. Head injury in the anticoagulated patient.
High Risk + Challenging Trauma Cases David Thompson, MD, MPH Hawaii Topics Head injury in the anticoagulated patient Shock recognition Case 1: Head injury HPI: 57 yo male w/ PMH atrial fibrillation, on
Adult Reversal of Anticoagulation and Anti-platelet Agents for Life- Threatening Bleeding or Emergency Surgery Protocol
Adult Reversal of Anticoagulation and Anti-platelet Agents for Life- Threatening Bleeding or Emergency Surgery Protocol Page Platelet Inhibitors 2 Aspirin, Clopidogrel (Plavix), Prasugrel (Effient) & Ticagrelor
Standardize comprehensive care of the patient with severe traumatic brain injury
Trauma Center Practice Management Guideline Iowa Methodist Medical Center Des Moines Management of Patients with Severe Traumatic Brain Injury (GCS < 9) ADULT Practice Management Guideline Contact: Trauma
EAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary
EAST MULTICENTER STUDY DATA DICTIONARY Temporary Intravascular Shunt Study Data Dictionary Data Entry Points and appropriate definitions / clarifications: Entry space Definition / Instructions 1. Specific
Q1 Contact Information
Q1 Contact Information Answered: 7 Skipped: 0 ANSWER CHOICES Hospital Name of Person Completing Survey Email RESPONSES 100.00% 7 100.00% 7 100.00% 7 # HOSPITAL DATE 1 Saint Luke's Hospital of Kansas City
Supplement Table 1. Definitions for Causes of Death
Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death
Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture
Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture Patients with hip fractures should be operated on within 36 hours of presentation wherever possible.
Transfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL
Minimal clinical evidence exists to support the efficacy of nonspecific procoagulant therapies that promote thrombin formation and antifibrinolytics in the setting of antithrombotic-related bleeding. Hemostatic
EAST MULTICENTER STUDY DATA COLLECTION TOOL
EAST MULTICENTER STUDY DATA COLLECTION TOOL Multicenter Study: Effect of Regional Anesthesia on Delirium in Geriatric Trauma Patients with Multiple Rib Fractures Enrolling Center: Enrolling Co-investigators:
New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel)
New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel) Limitations and Advantages of UFH and LMWH Biological limitations of UFH : 1. immune-mediated
ADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
PRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8
PRACTICE GUIDELINE Effective Date: 9-1-2012 Manual Reference: Deaconess Trauma Services TITLE: TRAUMATIC BRAIN INJURY GUIDELINE OBJECTIVE: To provide practice management guidelines for traumatic brain
Venous Thromboembolism National Hospital Inpatient Quality Measures
Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation
GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
The Michigan Trauma Quality Improvement Program. Ann Arbor, MI June 7, 2011
The Michigan Trauma Quality Improvement Program Ann Arbor, MI June 7, 2011 Information Current centers 14 New centers (July 1) Botsford Covenant Spectrum St. Johns Future centers (January 1) 23 Total Information
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) OBJECTIVE: To assist clinicians with the investigation and management of suspected and documented heparin-induced thrombocytopenia (HIT). BACKGROUND: HIT is a transient,
Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting
ACEP19 Emergency Department Utilization of CT for Minor Blunt Head Trauma for Aged 18 Years and Older Percentage of visits for aged 18 years and older who presented with a minor blunt head trauma who had
the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital
What do you do when the bleeding won t stop? Teddie Tanguay RN, MN, NP, CNCC(c) Teddie Tanguay RN, MN, NP, CNCC(c) Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital Outline Case study Normal coagulation
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
Multidisciplinary Geriatric Trauma Care Guideline
Multidisciplinary Geriatric Trauma Care Background Traumatic injury in the geriatric population is increasing in prevalence and is associated with higher mortality and complication rates comparted to younger
A Great Clinical Paradox. Narendranath Epperla MD Sowjanya Bapani MD Steven Yale MD, FACP
A Great Clinical Paradox Narendranath Epperla MD Sowjanya Bapani MD Steven Yale MD, FACP Initial Presentation 61 y/o Vietnam veteran with a past H/O hypertension, back pain and depression on Lisinopril,
a. A pharmacist may order a baseline SCr per protocol
UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Anticoagulant Therapy Per Practice Protocol (Formerly Anticoagulant therapy #NPSG.03.05.01) Inpatient Warfarin
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)
VENOUS THROMBOEMBOLISM PHARMACOLOGY. University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D
VENOUS THROMBOEMBOLISM PHARMACOLOGY University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D LEARNING OBJECTIVES Know what factors anticoagulant medications
Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults
Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults Purpose: To be used as a common tool for all practitioners involved in the care of patients
Datapoint Description On Tab On Report Data Element Name Type Values Default Validation
Datapoint Description On Tab On Report Data Element Name Type Values Default Validation 1=Never, 2=Field/Scene/ En Route, 3=ED, 4=OR, 5=ICU, 6=Other (Floor, Number with Radiology, Intubation status X X
Delayed Splenic Rupture After Non-Operative Management of Blunt Splenic Injury A AAST Multi-Institutional Prospective Trial Data Collection Tool
Delayed Splenic Rupture After Non-Operative Management of Blunt Splenic Injury A AAST Multi-Institutional Prospective Trial Data Collection Tool Enrolling Center: Patient Number (sequential within center):
Number with pick list. 5/6/2011 Michigan TQIP
Datapoint Description On Tab On Report Data Element Name Type Values Default Validation Intubation status X X MTQIP_INT_STAT list 1=Never, 2=Field/Scene/En Route, 3=ED, 4=OR, 5=ICU, 6=Other (Floor, Radiology,
Yes No Unknown. Major Infection Information
Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery
Study title: Safety of therapeutic anticoagulation in patients with traumatic brain injury: a multicenter prospective observational study
Study title: Safety of therapeutic anticoagulation in patients with traumatic brain injury: a multicenter prospective observational study Primary investigator: Kazuhide Matsushima, MD Email: kazuhide.matsushima@med.usc.edu
Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks
Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks 1. What is the most common cause of death in hospitalized patients? 1. Hospital-acquired infection 2. Pulmonary embolism 3. Myocardial infarction
Venous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
UPDATES, 2018 NTDS PILOT (PROPOSED CHANGES TO 2020 NTDB DATA DICTIONARY) AND TQIP PROCESS MEASURES. Lita Holdeman, BS, CSTR AOTR Education Chair
UPDATES, 2018 NTDS PILOT (PROPOSED CHANGES TO 2020 NTDB DATA DICTIONARY) AND TQIP PROCESS MEASURES Lita Holdeman, BS, CSTR AOTR Education Chair Disclaimer Notice: All information provide to you at any
Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015
Management of the Trauma Patient Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015 Saturday Night 25 yo M s/p high speed MVC Hypotensive in the ED, altered
Acute Stroke Protocols Modified- What s New in 2013
Acute Stroke Protocols Modified- What s New in 2013 KUMAR RAJAMANI, MD, DM. Vascular Neurologist-MSN Associate Professor of Neurology WSU School of Medicine. Saturday, September 21, 2013 Crystal Mountain
Clinical Controversies in Perioperative Medicine
Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative
DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.
Guideline for Patients on Direct Oral Anticoagulant Therapy Requiring Urgent Surgery for Hip Fracture Trust Ref:C10/2017 1. Introduction This guideline is for the clinical management of patients on direct
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism
R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital
R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY
THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is
The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.
Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1). 1 Inform Consent Date: / / dd / Mmm / yyyy 2 Patient identifier: Please enter the 6 digit Patient identification number from your site patient log
Datapoint Description On Tab On Report Data Element Name Type Values Default
CUSTOM DATA ELEMENTS FOR 2017 MTQIP TAB Datapoint Description On Tab On Report Data Element Name Type Values Default Intubation status X X MTQIP_INT_STAT Number with pick list 1=Never, 2=Field/Scene/En
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
Demographic Data Group Study Cohort Control p N 60 20 Age, Mean (years) 36.3 64.4 < 0.001 Age, Median (years) 33.2 64 < 0.001 Male 41 (68.4%) 4 (20%) 0.001 Female 19 (31.6%) 16 (80%) 0.001 Mechanism of
Process Measures Toolkit for 2016 Admissions
Process Measures Toolkit for 2016 Admissions Collection Criterion #1 Collect on all patients The following data fields should be reported using the listed field value option(s), or relevant value, as indicated
Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine
Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine Antithrombotics Antiplatelets Aspirin Ticlopidine Prasugrel Dipyridamole
HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
Prostate Biopsy Alerts
Prostate Biopsy Alerts Saskatchewan Prostate Assessment Pathway Guidelines for the Primary Care Provider for Patient Preparation and the Management of Medications and Complications September 2016 Table
CEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
Chapter 1 The Reversing Agents
Available Strategies to Reverse Anticoagulant Medications Michael L. Smith, Pharm. D., BCPS, CACP East Region Pharmacy Clinical Manager Hartford HealthCare Objectives: Describe the pharmacological agents
Orthopedic Admission Hip Fracture Version 2 1/25/2017
Patient Name: Initial each page and Sign/Date/Time last page Diagnosis: Allergies with reaction type: Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Placement Patient Status If the physician
Brain vs. Bone: Does fracture fixation technique influence outcomes in patients with traumatic brain injury (TBI)?
EAST MULTICENTER STUDY DATA COLLECTION TOOL Brain vs. Bone: Does fracture fixation technique influence outcomes in patients with traumatic brain injury (TBI)? 1.Patient Number: The following sheets are
Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine
Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates
PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP
PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT
CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT
CRRT Fundamentals Pre-Test AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling at home. He
Thrombolysis administration
Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide
Mabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
TEVAR for trauma is here to stay: Advances in the Treatment of Blunt Thoracic Aortic Injury
TEVAR for trauma is here to stay: Advances in the Treatment of Blunt Thoracic Aortic Injury Megan Brenner MD MS RPVI FACS Associate Professor of Surgery Division of Trauma/Surgical Critical Care, RA Cowley
TRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital
TRAUMA RESUSCITATION Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital First Principles.ATLS/EMST A- Airway and C-spine B- Breathing C- Circulation and Access D- Neurological deficit E- adequate
www.yassermetwally.com MANAGEMENT OF CEREBRAL HAEMORRHAGE (ICH): A QUICK GUIDE Overview 10% of strokes is caused by ICH. Main Causes: Less than 40 years old: vascular malformations and illicit drug use.
Nitroglycerin and Heparin Drip Interfacility Protocols
Nitroglycerin and Heparin Drip Interfacility Protocols EMS Protocol This protocol applies to nitroglycerin and Heparin drips that are initiated at the transferring facility prior to transport and are not
WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT
WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT - Entering orders for anticoagulation in Cerner Providers will enter individual orders (oneoffs)
FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS
New Horizons In Atherothrombosis Treatment 2012 순환기춘계학술대회 FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS Division of Cardiology, Jeonbuk National University Medical School Jei Keon Chae,
Do s and Don t of DOACs DISCLOSURE
Do s and Don t of DOACs Tom DeLoughery, MD MACP FAWM Oregon Health and Sciences University DISCLOSURE Relevant Financial Relationship(s) Speaker Bureau - None Consultant/Research none Content Expert: Elsevier
Lutheran Medical Center Department of Surgery
Lutheran Medical Center Department of Surgery Morbidity & Mortality Conference Case & Topic Presentation Baiju C. Gohil, M.D. April 9, 2004 FAT EMBOLISM SYNDROME INTRODUCTION Fat emboli were first noted
Bladder Trauma Data Collection Sheet
Bladder Trauma Data Collection Sheet If there was no traumatic injury with PENETRATION of the bladder DO NOT proceed Date of injury: / / Time of injury: Date of hospital arrival: / / Time of hospital arrival:
ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4
TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Transfer to: 10 South Attending Physician: Diagnosis:
Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary
Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Increasing use of Novel Oral Anticoagulants (NOACs) in the management of prophylaxis and management of venous thromboembolism and in
Michael Avant, M.D. The Children s Hospital of GHS
Michael Avant, M.D. The Children s Hospital of GHS OVERVIEW ER to ICU Transition Early Management Priorities the First 48 hours Organ System Support Complications THE FIRST 48 HOURS Communication Damage
Page 1 of 6. Low 1 (score 0-3) Monitor platelets and signs and symptoms of thrombosis and continue heparin
Page 1 of 6 Estimate probability of HIT using the Four T s 1 Low 1 (score 0-3) Intermediate 1 (score 4-5) or High 1 (score 6-8) Monitor platelets and signs and symptoms of thrombosis and continue heparin
Asif Serajian DO FACC FSCAI
Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac
New Strategies in the Management of Patients with Severe Sepsis
New Strategies in the Management of Patients with Severe Sepsis Michael Zgoda, MD, MBA President, Medical Staff Medical Director, ICU CMC-University, Charlotte, NC Factors of increases in the dx. of severe
Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18
Blood Product Utilization A Mythbusters! Style Review Amanda Haynes, DO 4/28/18 Objectives Describe concepts in Patient Blood Management Review common misconceptions surrounding blood transfusion Summarize
ECLS Registry Form Extracorporeal Life Support Organization (ELSO)
ECLS Registry Form Extracorporeal Life Support Organization (ELSO) Center ID: Center name: Run No (for this patient) Unique ID: Birth Date/Time Sex: (M, F) Race: (Asian, Black, Hispanic, White, Other)
Guideline for Treatment of Head Injury in the Anticoagulated Patient
Guideline for Treatment of Head Injury in the Anticoagulated Patient GUIDELINE: GUIDELINE FOR TREATMENT OF HEAD INJURY IN THE ANTICOAGULATED PATIENT BACKGROUND: Chronic anticoagulation therapy is used
Canadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet
Canadian Trauma Trials Collaborative STUDY CENTRE: Institution: City / Province: / Occult Pneumothorax in Critical Care (OPTICC): Standardized Sheet PATIENT DEMOGRAPHICS: First Name: Health record number
Reversal of Anticoagulants at UCDMC
Reversal of Anticoagulants at UCDMC Introduction: Bleeding complications are a common concern with the use of anticoagulant agents. In selected situations, reversing or neutralizing the effects of an anticoagulant
Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข
Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke
INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests
Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash
Reducing the Use of Reversal Agents in a Community Hospital
4//0 Objectives Reducing the Use of Reversal Agents in a Community Hospital Maria Paulina Duarte, PharmD PGY- Pharmacy Resident Mercy Hospital, A Campus of Plantation General Hospital Review the appropriate
October 2017 Pulmonary Embolism
October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment
2.5 Other Hematology Consult:
The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR
Head injuries. Severity of head injuries
Head injuries ED Teaching day 23 rd October Severity of head injuries Minor GCS 14-15 Must not have any of the following: Amnesia 10min Neurological sign or symptom Skull fracture (clinically or radiologically)
Traumatic Brain Injuries
Traumatic Brain Injuries Scott P. Sherry, MS, PA-C, FCCM Assistant Professor Department of Surgery Division of Trauma, Critical Care and Acute Care Surgery DISCLOSURES Nothing to disclose Discussion of
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
New Oral Anticoagulants
New Oral Anticoagulants Tracy Minichiello, MD Associate Professor of Medicine Chief, San FranciscoVA Anticoagulation and Thrombosis Services What percentage of time do patients on warfarin spend in therapeutic
Guide to completing the MODET study CRF
Guide to completing the MODET study CRF Please record ND for not documented, NA for not applicable and UK for unknown rather than leave blank fields. CRF PAGE 1. Time of injury Complete the time of injury
A Comparative Analysisof Male versus Female Breast Cancer in the ACS NSQIP Database
A Comparative Analysisof Male versus Female Breast Cancer in the ACS NSQIP Database Lindsay Petersen, MD Rush University Medical Center Chicago, IL I would like to recognize my coauthors: Andrea Madrigrano,
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
Emergent Anticoagulation Reversal
U N C M E D I C A L C E N T E R G U I D E L I N E Emergent Anticoagulation Reversal I. PURPOSE: The purpose of these instructions is to provide guidelines for the reversal of or management of bleeding
Emergency Room Procedure The first few hours in hospital...
Emergency Room Procedure The first few hours in hospital... ER 5 level Emergency Severity Index SOP s for Stroke Stroke = Level 2 Target Time = 1 Hour 10 min from door 2 Doctor 25 min from door 2 CT 60
SAMPLE Data Entry Manual for the veds Project
The data entry manual is designed to provide a clear definition for each variable collected and the options for each variable SAMPLE Data Entry Manual for the veds Project Subject ID Each study participant